%0 Journal Article
%T Improving Compliance With a Single Post-Operative Dose of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumour
%A Ben Tschobotko
%A David Ellis
%A Elsie Mensah
%A Evangelos Mazaris
%A Hamid Abboudi
%A Harikesh Kaneshayogan
%A Luke Stroman
%J Archive of "Nephro-urology Monthly".
%D 2016
%R 10.5812/numonthly.29967
%X Post-operative single dose intravesical chemotherapy (PSDIVC) in patients with non-muscle invasive bladder cancer has been shown to reduce recurrence rates by up to 39%. However, some studies have suggested poor compliance with PSDIVC stating logistical issues and reluctance to give chemotherapy prior to histological confirmation as some of the reasons
%K Mitomycin C
%K Bladder Cancer
%K Intravesical Instillation
%K Bladder Neoplasms
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779310/